Baillie Gifford & Co’s Myriad Genetics MYGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-8,970,006
| Closed | -$128M | – | 247 |
|
2020
Q1 | $128M | Buy |
8,970,006
+4,828
| +0.1% | +$69.1K | 0.14% | 92 |
|
2019
Q4 | $244M | Sell |
8,965,178
-278,625
| -3% | -$7.59M | 0.24% | 83 |
|
2019
Q3 | $265M | Sell |
9,243,803
-283,339
| -3% | -$8.11M | 0.3% | 74 |
|
2019
Q2 | $265M | Sell |
9,527,142
-13,444
| -0.1% | -$373K | 0.28% | 75 |
|
2019
Q1 | $317M | Buy |
9,540,586
+55,642
| +0.6% | +$1.85M | 0.35% | 67 |
|
2018
Q4 | $276M | Sell |
9,484,944
-62,249
| -0.7% | -$1.81M | 0.36% | 64 |
|
2018
Q3 | $439M | Buy |
9,547,193
+92,008
| +1% | +$4.23M | 0.47% | 53 |
|
2018
Q2 | $353M | Sell |
9,455,185
-107,778
| -1% | -$4.03M | 0.38% | 56 |
|
2018
Q1 | $283M | Sell |
9,562,963
-62,883
| -0.7% | -$1.86M | 0.33% | 60 |
|
2017
Q4 | $331M | Buy |
9,625,846
+15,309
| +0.2% | +$526K | 0.41% | 57 |
|
2017
Q3 | $348M | Sell |
9,610,537
-54,710
| -0.6% | -$1.98M | 0.44% | 52 |
|
2017
Q2 | $250M | Sell |
9,665,247
-257,206
| -3% | -$6.65M | 0.34% | 62 |
|
2017
Q1 | $191M | Sell |
9,922,453
-237,305
| -2% | -$4.56M | 0.28% | 72 |
|
2016
Q4 | $169M | Sell |
10,159,758
-290,064
| -3% | -$4.84M | 0.28% | 69 |
|
2016
Q3 | $215M | Sell |
10,449,822
-871,476
| -8% | -$17.9M | 0.34% | 62 |
|
2016
Q2 | $346M | Sell |
11,321,298
-45,738
| -0.4% | -$1.4M | 0.62% | 44 |
|
2016
Q1 | $425M | Buy |
11,367,036
+50,708
| +0.4% | +$1.9M | 0.75% | 34 |
|
2015
Q4 | $488M | Buy |
11,316,328
+629,570
| +6% | +$27.2M | 0.85% | 32 |
|
2015
Q3 | $401M | Buy |
10,686,758
+311,000
| +3% | +$11.7M | 0.78% | 38 |
|
2015
Q2 | $353M | Buy |
10,375,758
+448,399
| +5% | +$15.2M | 0.63% | 43 |
|
2015
Q1 | $351M | Buy |
9,927,359
+268,356
| +3% | +$9.5M | 0.67% | 43 |
|
2014
Q4 | $329M | Buy |
9,659,003
+675,100
| +8% | +$23M | 0.66% | 44 |
|
2014
Q3 | $347M | Buy |
8,983,903
+198,400
| +2% | +$7.65M | 0.76% | 38 |
|
2014
Q2 | $342M | Buy |
8,785,503
+118,400
| +1% | +$4.61M | 0.74% | 37 |
|
2014
Q1 | $296M | Buy |
8,667,103
+4,118,403
| +91% | +$141M | 0.7% | 44 |
|
2013
Q4 | $95.4M | Buy |
4,548,700
+885,300
| +24% | +$18.6M | 0.23% | 73 |
|
2013
Q3 | $86.1M | Buy |
+3,663,400
| New | +$86.1M | 0.22% | 75 |
|